Clinical Trials Browser

Phase 1 × Congenital Abnormalities × HDAC-42 × Clear all

NCT01798901 2018-03-14

AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia

Phase 1 Completed

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Myeloid, Acute